Allianz Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $66.2M | Sell |
|
|||||
2025
Q1 | $91.4M | Buy |
|
|||||
2024
Q4 | $82M | Buy |
|
|||||
2024
Q3 | $102M | Sell |
|
|||||
2024
Q2 | $122M | Sell |
|
|||||
2024
Q1 | $134M | Sell |
|
|||||
2023
Q4 | $186M | Sell |
|
|||||
2023
Q3 | $199M | Buy |
|
|||||
2023
Q2 | $214M | Buy |
|
|||||
2023
Q1 | $194M | Buy |
|
|||||
2022
Q4 | $161M | Buy |
|
|||||
2022
Q3 | $151M | Sell |
|
|||||
2022
Q2 | $122M | Buy |
|
|||||
2022
Q1 | $112M | Buy |
|
|||||
2021
Q4 | $112M | Buy |
|
|||||
2021
Q3 | $88.3M | Buy |
|
|||||
2021
Q2 | $70.1M | Sell |
|
|||||
2021
Q1 | $65.2M | Sell |
|
|||||
2020
Q4 | $86.8M | Buy |
|
|||||
2020
Q3 | $86.9M | Sell |
|
|||||
2020
Q2 | $162M | Buy |
|
|||||
2020
Q1 | $184M | Sell |
|
|||||
2019
Q4 | $188M | Buy |
|
|||||
2019
Q3 | $132M | Sell |
|
|||||
2019
Q2 | $147M | Sell |
|
|||||
2019
Q1 | $160M | Buy |
|
|||||
2018
Q4 | $197M | Buy |
|
|||||
2018
Q3 | $199M | Sell |
|
|||||
2018
Q2 | $203M | Sell |
|
|||||
2018
Q1 | $214M | Buy |
|
|||||
2017
Q4 | $201M | Buy |
|
|||||
2017
Q3 | $176M | Buy |
|
|||||
2017
Q2 | $146M | Buy |
|
|||||
2017
Q1 | $146M | Sell |
|
|||||
2016
Q4 | $204M | Buy |
|
|||||
2016
Q3 | $218M | Sell |
|
|||||
2016
Q2 | $206M | Sell |
|
|||||
2016
Q1 | $223M | Buy |
|
|||||
2015
Q4 | $247M | Sell |
|
|||||
2015
Q3 | $260M | Sell |
|
|||||
2015
Q2 | $409M | Buy |
|
|||||
2015
Q1 | $377M | Buy |
|
|||||
2014
Q4 | $282M | Sell |
|
|||||
2014
Q3 | $337M | Sell |
|
|||||
2014
Q2 | $334M | Buy |
|
|||||
2014
Q1 | $308M | Buy |
|
|||||
2013
Q4 | $278M | Sell |
|
|||||
2013
Q3 | $249M | Sell |
|
|||||
2013
Q2 | $245M | Buy |
|